Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;4(1):29.
doi: 10.1007/s42399-021-01094-w. Epub 2022 Jan 10.

Eyelid Myokymia-a Presumed Manifestation of Coronavirus Disease 2019 (COVID-19)

Hashim Ali Khan  1   2 , Muhammad Aamir Shahzad  3 , Smaha Jahangir  2 , Junaid Iqbal  1 , Suhail Abbas Juwa  1 , Qaim Ali Khan  4 , Munib-Ur-Rehman  5 , Naeemullah Khan  6 , Muhammad Afzal  7 , Fatima Iqbal  2   8
Affiliations

Eyelid Myokymia-a Presumed Manifestation of Coronavirus Disease 2019 (COVID-19)

Hashim Ali Khan et al. SN Compr Clin Med. 2022.

Abstract

The purpose of this study is to report eyelid myokymia in patients recently recovered from COVID-19 disease. A cohort of 15 patients who developed eyelid myokymia during or immediate post-recovery of systemic disease were evaluated. Demographic, clinical characteristics, effect of age, and hospitalization on the disease course were studied. The disease course was evaluated every month for 3 months period. All, except 2, patients had complete resolution of lid myokymia within 3 months of onset. Median [IQR] myokymia recovery time was 42 [31,60] days. Age and duration of hospitalization had a significant linear relationship with myokymia recovery time. Recovery was delayed by 2.64 days with every 1-year increment in age and by 6.19 days with every additional day of hospital stay. Recovery time was independent of severity of systemic disease (P = .055) and gender (P = 0.2). Eyelid myokymia can be a possible manifestation of COVID-19 recovery phase. While myokymia recovers gradually in all these patients, older age and a longer duration of hospitalization are associated with slower recovery.

Keywords: Blepharospasm; COVID-19; Coronavirus; Eyelid myokymia.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestThe authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The myokymia pattern and course
Fig. 2
Fig. 2
Relationship between age and myokymia recovery time
Fig. 3
Fig. 3
Effect of length of hospital stay on myokymia recovery time
See this image and copyright information in PMC

References

    1. Yamamoto V, Bolanos JF, Fiallos J, Strand SE, Morris K, Shahrokhinia S, et al. COVID-19: review of a 21st century pandemic from etiology to neuro-psychiatric implications. J Alzheimers Dis. 2020;77(2):459–504. doi: 10.3233/jad-200831. - DOI - PMC - PubMed
    1. WHO Coronavirus Disease (COVID-19) Dashboard. 2021. https://covid19.who.int/. Accessed 12/01/2021 2021.
    1. Bostanci Ceran B, Ozates S. Ocular manifestations of coronavirus disease 2019. Graefes Arch Clin Exp Ophthalmol. 2020;258(9):1959–1963. doi: 10.1007/s00417-020-04777-7. - DOI - PMC - PubMed
    1. Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. doi: 10.1080/09273948.2020.1738501. - DOI - PMC - PubMed
    1. Bertoli F, Veritti D, Danese C, Samassa F, Sarao V, Rassu N, et al. Ocular findings in COVID-19 patients: a review of direct manifestations and indirect effects on the eye. J Ophthalmol. 2020;2020:4827304. doi: 10.1155/2020/4827304. - DOI - PMC - PubMed

LinkOut - more resources